Review of status of HIV strain diversity in the United States

Journal of Medical Virology

Volumn 79, Issue SUPPL. 1, 2007, Pages

  Brennan, Catherine A ^a  

^a ABBOTT DIAGNOSTICS   (United States)

Author keywords

HIV diversity; HIV surveillance; HIV 1 non B subtypes

Indexed keywords

BIODIVERSITY; BLOOD TRANSFUSION; CONFERENCE PAPER; ENDEMIC DISEASE; EUROPE; FRANCE; GENETIC RISK; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 GROUP M; HUMAN IMMUNODEFICIENCY VIRUS 1 GROUP M SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMIGRATION; MILITARY MEDICINE; NONHUMAN; SEXUAL TRANSMISSION; UNITED STATES; VERTICAL TRANSMISSION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS TYPING;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34748923754     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20971     Document Type: Conference Paper

References (41)

1. Achkar JM, Burda ST, Konings FAJ, Urbanski MM, Williams CAU, Seifen D, Kahirimbanyi MN, Vogler M, Parta M, Lupatkin HC, Zolla-Pazner S, Nyambi PN. 2004. Infection with HIV type 1 group M non-B subtypes in individuals living in New York City. J Acquir Immune Defic Syndr 36:835-844.
2. Barin F, Plantier J-C, Brand D, Brunet S, Moreau A, Liandier B, Thierry D, Cazein F, Lot F, Semaille C, Desenclos J-C. 2006. Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic. J Med Virol 78:S13-S18.
3. Bennett D. 2005. HIV-1 genetic diversity surveillance in the United States. J Infect Dis 192:4-9.
4. Brodine SK, Starkey MJ, Shaffer RA, Ito SI, Tasker SA, Barile AJ, Tamminga CL, Stephan KT, Aronson NE, Fraser SL, Wallace MR, Wegner SA, Mascola JR, McCutchan FE. 2003. Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort. AIDS 17:2521-2527.
5. Cartwright CP. 2006. The changing epidemiology of HIV/AIDS at a Minnesota hospital: Impact of demographic change and viral diversity. J Med Virol 78:S19-S21.
6. de Oliveira CF, Diaz RS, Machado DM, Sullivan MT, Finlayson T, Gwinn M, Lackritz EM, Williams AE, Kessler D, Operskalski EA, Mosley JW, Busch MP. 2000. Surveillance of HIV-1 genetic subtypes and diversity in the US blood supply. Transfusion 40:1399-1406.
7. DeCock KM, Adjorlolo G, Ekpine E, Sibailly T, Kouadio J, Maran M, Brattegaard K, Vetter KM, Doorly R, Gayle HD. 1993. Epidemiology and transmission of HIV-2: Why there is no HIV-2 pandemic. JAMA 270:2083-2086.
8. Delwart EL, Orton S, Parekh B, Dobbs T, Clark K, Busch MP. 2003. Two percent of HIV-positive U.S. blood donors are infected with non-subtype B strains. AIDS Res Hum Retrovir 19:1065-1070.
9. Eshleman S, Hackett J, Jr., Cunningham SP, Drews B, Swanson P, Brennan C, Devare SG, Zekeng L, Kaptué L, Marlowe N. 2004. Performance of the Celera Diagnostics ViroSeq™ HIV-1 Genotyping System v2.0 for sequence-based analysis of diverse HIV-1 strains. J Clin Microbiol 42:2711-2717.
10. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Klienman SH, Busch MP. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary infection. AIDS 17:1871-1879.
11. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, Sharp PM, Hahn BH. 1999. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436-441.
12. Gaudy C, Moreau A, Brunet S, Descamps J-M, Deleplanque P, Brand D, Barin F. 2004. Subtype B human immunodeficiency virus (HIV) type 1 mutant that escapes detection in a fourth-generation immunoassay for HIV infection. J Clin Microbiol 42:2847-2849.
13. Geelen S, Lange J, Borleffs J, Wolfs T, Weersink A, Schuurman R. 2003. Failure to detect a non-B HIV-1 subtype by the Amplicor Monitor test, version 1.5: A case of unexpected vertical transmission. AIDS 17:781-782.
14. Gonzales MJ, Machekano RN, Shafer RW. 2001. Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a Northern California clinic-based population. J Infect Dis 184:998-1006.
15. Hanna GJ, Balaguera HU, Freedberg KA, Werner BG, Steger, Craven KA, Craven DE, D'Aquila RT. 2003. Drug-selected resistance mutations and non-B subtypes in antiviral-naive adults with established human immunodeficiency virus infection. J Infect Dis 188:986-991.
16. Harris B, von Truchsess I, Schätzl HM, Devare SG, Hackett J, Jr. 2005. Genomic characterization of a novel HIV-1 B/G intersubtype recombinant strain from an injecting drug user in Germany. AIDS Res Hum Retrovir 21:654-660.
17. Herr MD, Hathcock AL, Hamaker DW, Schulte JM, Hoehns D, Mitchell BE, Simpson DM. 1995. Update: HIV-2 infection among blood and plasma donors - United States, June 1992-June 1995. MMWR 44: 603-606.
18. Hirigoyen DL, Cartwright CP. 2005. Use of sequence data generated in the Bayer TruGene genotyping assay to recognize and characterize non-subtype-B human immunodificiency virus type 1 strains. J Clin Mircobiol 43:5263-5271.
19. Karchava M, Pulver W, Smith L, Philpott S, Sullivan TJ, Wethers J, Parker MM. 2006. Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State. J Acquir Immune Defic Syndr 42:614-617.
20. Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Mpoudi Ngolle E, Bienvenue Y, Delaporte E, Brookfield JFY, Sharp PM, Shaw GM, Peeters M, Hahn BH. 2006. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313:523-526.
21. Lee S, Hu J, Tang S, Wood O, Francis K, Machuca A, Rios M, Daniel S, Vockley C, Awazi B, Zekeng L, Hewlett I. 2006. Evaluation of FDA licensed HIV assays using plasma from Cameroonian blood donors. J Med Virol 78:S22-S23.
22. Lin H-H, Gaschen BK, Collie M, El-Fishaway M, Chen Z, Korber BT, Beatrice ST, Zhang L. 2006. Genetic characterization of diverse HIV-1 strains in an immigrant population living in New York City. J Acquir Immune Defic Syndr 41:399-404.
23. Lot F, Semaille C, Cazein F, Barin F, Pinget R, Pillonel J, Desenclos JC. 2004. Preliminary results from the new HIV surveillance system in France. Eurosurveillance 9:34-37.
24. Ly TD, Martin L, Daghfal D, Sandridge A, West D, Bristow R, Chalouas L, Qiu X, Lou SC, Hunt JC, Schochetman G, Devare SG. 2001. Seven human immunodeficiency virus antigen-antibody combination assays: Evaluation of HIV seroconversion sensitivity and subtype detection. J Clin Microbiol 39:3122-3128.
25. Ly TD, Laperche S, Brennan C, Vallari A, Ebel A, Hunt J, Martin L, Daghfal D, Schochetman G, Devare S. 2004. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J Virol Meth 122:185-194.
26. McCutchan FE. 2006. Global epidemiology of HIV. J Med Virol 78:S7-S12.
27. Parry JV, Murphy G, Barlow KL, Lewis K, Rogers PA, Belda FJ, Nicoll A, McGarrigle C, Cliffe S, Mortimer PP, Clewley JP. 2001. National surveillance of HIV-1 subtypes for England and Wales: Design, methods, and initial findings. J Acquir Immune Defic Syndr 26: 381-388.
28. Rayfield MA, Sullivan P, Bandea CJ, Britvan L, Otten RA, Pau CP, Pieniazek D, Subbarao S, Simon P, Schable CA, Wright AC, Ward J, Schochetman G. 1996. HIV-1 group O virus identified for the first time in the United States. Emerging Infect Dis 2:209-212.
29. Roques P, Robertson DL, Souquières S, Ayouba A, Nerrienet E, Barré-Sinoussi F, Muller-Trutwin M, Simon F. 2004. Phylogenetic characteristics of three new HIV-1 group N strains and implications for the origin of group N. AIDS 18:1371-1381.
30. Schable C, Zekeng L, Pau C-P, Hu D, Kaptue L, Gürtler L, Dondero T, Tsague J-M, Schochetman G, Jaffe H, George JR. 1994. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 343:1393-1394.
31. Sides TL, Akinsete O, Henry K, Wotton JT, Carr PW, Bartkus J. 2005. HIV-1 subtype diversity in Minnesota. J Infect Dis 192:37-45.
32. Sullivan PS, Do AN, Robbins K, Kalish M, Subbarao S, Pieniazek D, Schable C, Afaq G, Markowitz J, Myers R, Joseph JM, Benjamin G. 1997. Surveillance for variant strains of HIV: Subtype G and group O HIV-1. JAMA 278:292.
33. Swanson P, Harris BJ, Holzmayer V, Devare SG, Schochetman G, Hackett J, Jr. 2000. Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA Quantitative Assay. J Virol Meth 89:97-108.
34. Swanson P, de Mendoza C, Joshi J, Golden A, Hodinka RL, Soriano V, Devare SG, Hackett J, Jr. 2005. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx® HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR version 1.5, Quantiplex HIV RNA version 3.0, and NucliSens HIV-1 QT. J Clin Microbiol 43:3860-3868.
35. Swanson P, Huang S, Holzmayer V, Bodelle P, Yamaguchi J, Brennan C, Badaro R, Brites C, Abravaya K, Devare SG, Hackett J, Jr. 2006a. Performance of the automated Abbott RealTime™ HIV-1 assay on a genetically diverse panel of specimens from Brazil. J Virol Meths 134:237-243.
36. Swanson P, Holzmayer V, Huang S, Hay P, Adebiyi A, Rice P, Abravaya K, Thamm S, Devare SG, Hackett J, Jr. 2006b. Performance of the automated Abbott RealTime™ HIV-1 assay on a genetically diverse panel of specimens from London: Comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v 1.5, AND LCx® HIV RNA Quantitative assays. J Virol Meths 137:184-192.
37. Swanson P, Huang S, Abravaya K, de Mendoza C, Soriano V, Devare SG, Hackett J, Jr. 2007. Evaluation of performance across the dynamic range of the Abbott RealTime® HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v 1.5 using serial dilutions of 39 group M and O viruses. J Virol Meths 141:49-57.
38. Van Heuverswyn F, Li Y, Neel C, Bailes E, Keele BF, Liu W, Loul S, Butel C, Liegeois F, Bienvenue Y, Mpoudi Ngolle E, Sharp PM, Shaw GM, Delaporte E, Hahn BH, Peeters M. 2006. SIV infection in wild gorillas. Nature 444:164.
39. Weidle PJ, Ganea CE, Irwin KL, Pieniazek D, McGowan JP, Olivo N, Ramos A, Schable C, Lal RB, Holmberg SD, Ernst JA. 2000. Presence of human immunodeficiency virus (HIV) type 1, group M, non-B Subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States. J infect Dis 181:470-475.
40. Womack C, Roth W, Newman C, Rissing JP, Lovell R, Haburchak D, Essex M, Bond VC. 2001. Identification of non-B human immunodeficiency virus type 1 subtypes in rural Georgia. J Infect Dis 183:138-142.
41. Yamaguchi J, Coffey R, Vallari A, Ngansop C, Mbanya D, Ndembi N, Kaptué L, Gürtler LG, Bodelle P, Schochetman G, Devare SG, Brennan CA. 2005. Identification of HIV-1 group N infections in a husband and wife in Cameroon: Viral genome sequences provide evidence for horizontal transmission. AIDS Res Hum Retrovir 22: 83-92.